Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 17 | 2019 | 1209 | 1.410 |
Why?
|
| Leukoaraiosis | 7 | 2019 | 45 | 1.070 |
Why?
|
| Brain Ischemia | 8 | 2019 | 418 | 0.620 |
Why?
|
| Cerebral Hemorrhage | 4 | 2017 | 100 | 0.490 |
Why?
|
| Headache | 2 | 2013 | 58 | 0.400 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 87 | 0.380 |
Why?
|
| Migraine Disorders | 1 | 2013 | 45 | 0.370 |
Why?
|
| Thrombolytic Therapy | 4 | 2019 | 195 | 0.370 |
Why?
|
| Fibrinolytic Agents | 2 | 2013 | 178 | 0.330 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 15 | 0.320 |
Why?
|
| Connective Tissue | 1 | 2010 | 11 | 0.310 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2010 | 5 | 0.310 |
Why?
|
| Vertebral Artery Dissection | 1 | 2010 | 22 | 0.310 |
Why?
|
| Retrospective Studies | 19 | 2019 | 6860 | 0.270 |
Why?
|
| Critical Care | 1 | 2011 | 402 | 0.260 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2007 | 21 | 0.250 |
Why?
|
| Aged, 80 and over | 15 | 2019 | 5607 | 0.250 |
Why?
|
| Dystonia | 1 | 2007 | 13 | 0.250 |
Why?
|
| Dexmedetomidine | 1 | 2007 | 10 | 0.250 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2007 | 21 | 0.250 |
Why?
|
| White Matter | 2 | 2019 | 126 | 0.250 |
Why?
|
| Recovery of Function | 4 | 2019 | 291 | 0.250 |
Why?
|
| Endovascular Procedures | 5 | 2017 | 626 | 0.240 |
Why?
|
| Brain | 3 | 2017 | 1603 | 0.230 |
Why?
|
| Risk Factors | 11 | 2019 | 5429 | 0.220 |
Why?
|
| Brain Injuries | 1 | 2007 | 141 | 0.220 |
Why?
|
| Aged | 20 | 2019 | 14952 | 0.210 |
Why?
|
| Atrial Fibrillation | 3 | 2018 | 879 | 0.210 |
Why?
|
| Severity of Illness Index | 7 | 2019 | 1559 | 0.210 |
Why?
|
| Cerebrum | 2 | 2015 | 16 | 0.200 |
Why?
|
| Male | 22 | 2019 | 31025 | 0.190 |
Why?
|
| Middle Aged | 17 | 2019 | 18262 | 0.180 |
Why?
|
| Humans | 28 | 2019 | 65109 | 0.180 |
Why?
|
| Cerebral Angiography | 5 | 2014 | 299 | 0.160 |
Why?
|
| Female | 21 | 2019 | 34008 | 0.160 |
Why?
|
| Treatment Outcome | 9 | 2019 | 5784 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 2244 | 0.160 |
Why?
|
| Bed Rest | 1 | 2019 | 11 | 0.160 |
Why?
|
| Vitamin K | 1 | 2019 | 15 | 0.150 |
Why?
|
| Cerebral Infarction | 3 | 2016 | 85 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 1656 | 0.150 |
Why?
|
| Mechanical Thrombolysis | 1 | 2019 | 36 | 0.150 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 69 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2010 | 186 | 0.140 |
Why?
|
| Hematoma | 1 | 2019 | 84 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2019 | 25 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 96 | 0.140 |
Why?
|
| Time-to-Treatment | 2 | 2016 | 134 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 169 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2016 | 164 | 0.130 |
Why?
|
| Prognosis | 4 | 2018 | 1785 | 0.120 |
Why?
|
| Stroke Volume | 1 | 2018 | 342 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 285 | 0.120 |
Why?
|
| Eligibility Determination | 1 | 2016 | 37 | 0.120 |
Why?
|
| Neuroimaging | 2 | 2016 | 164 | 0.120 |
Why?
|
| Patient Transfer | 2 | 2016 | 93 | 0.120 |
Why?
|
| Embolism | 1 | 2016 | 41 | 0.120 |
Why?
|
| Stroke, Lacunar | 1 | 2015 | 4 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1113 | 0.110 |
Why?
|
| Thrombophilia | 1 | 2015 | 14 | 0.110 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 14 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 117 | 0.110 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 12 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2019 | 525 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 42 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 108 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 112 | 0.100 |
Why?
|
| Vitamin D | 1 | 2015 | 139 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2016 | 223 | 0.100 |
Why?
|
| Patient Selection | 1 | 2016 | 483 | 0.100 |
Why?
|
| Length of Stay | 1 | 2017 | 827 | 0.100 |
Why?
|
| Apraxias | 1 | 2013 | 7 | 0.100 |
Why?
|
| Speech Disorders | 1 | 2013 | 18 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 292 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2013 | 63 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2014 | 497 | 0.090 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 930 | 0.090 |
Why?
|
| Air Ambulances | 1 | 2013 | 32 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 83 | 0.090 |
Why?
|
| Risk Assessment | 5 | 2018 | 2102 | 0.090 |
Why?
|
| Logistic Models | 4 | 2017 | 1270 | 0.090 |
Why?
|
| Adult | 8 | 2019 | 17353 | 0.090 |
Why?
|
| International Cooperation | 1 | 2011 | 87 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2014 | 333 | 0.080 |
Why?
|
| Heart Failure | 1 | 2018 | 954 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2010 | 30 | 0.080 |
Why?
|
| Enteral Nutrition | 1 | 2010 | 53 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 74 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 43 | 0.080 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 12 | 0.080 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2009 | 5 | 0.080 |
Why?
|
| Disability Evaluation | 3 | 2018 | 216 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 30 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 699 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1149 | 0.070 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 110 | 0.070 |
Why?
|
| Sympathetic Nervous System | 1 | 2008 | 35 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 991 | 0.070 |
Why?
|
| Chest Pain | 1 | 2008 | 85 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 736 | 0.060 |
Why?
|
| Time Factors | 3 | 2019 | 3762 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2016 | 754 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 268 | 0.060 |
Why?
|
| Heart | 1 | 2008 | 297 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 405 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 414 | 0.050 |
Why?
|
| Animals | 2 | 2013 | 21308 | 0.050 |
Why?
|
| Intracranial Aneurysm | 1 | 2008 | 382 | 0.050 |
Why?
|
| Registries | 2 | 2016 | 919 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2619 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2019 | 54 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 371 | 0.030 |
Why?
|
| Radiography | 1 | 2019 | 555 | 0.030 |
Why?
|
| Triage | 1 | 2017 | 135 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2015 | 10 | 0.030 |
Why?
|
| Patient Admission | 1 | 2017 | 198 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 510 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 213 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 576 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1163 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 602 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 171 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1698 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2017 | 420 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 261 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2013 | 34 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 1219 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2013 | 126 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 663 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1445 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2483 | 0.020 |
Why?
|
| Boston | 1 | 2010 | 258 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 139 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1479 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 44 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1693 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2008 | 51 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 2061 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 104 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 240 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 554 | 0.010 |
Why?
|
| Child | 1 | 2013 | 4612 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4810 | 0.010 |
Why?
|
| United States | 1 | 2015 | 8093 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3307 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 6305 | 0.010 |
Why?
|